Ibaraki, Japan

Yukiko Kurita

This inventor holds 2 USPTO granted patents. Top assignee: Tsumura Co., Ltd.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukiko Kurita. Retrieved from https://idiyas.com/inventor/yukiko-kurita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yukiko Kurita

Introduction

Yukiko Kurita is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic potential. With a total of 2 patents to her name, her work continues to impact the industry positively.

Latest Patents

Kurita's latest patents include innovative iridoid derivatives and neovascularization inhibitors. These compounds are represented by a general formula and are designed to serve as active ingredients in various therapeutic applications. Her research focuses on the potential of these derivatives to address critical health issues.

Career Highlights

Throughout her career, Yukiko Kurita has been associated with Tsumura Co., Ltd., a company known for its dedication to research and development in the pharmaceutical sector. Her work has been instrumental in advancing the understanding of iridoid compounds and their applications in medicine.

Collaborations

Kurita has collaborated with notable colleagues, including Masaharu Kigawa and Chiaki Sakakibara. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yukiko Kurita's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…